Cullaro Giuseppe, Allegretti Andrew S, Fenton Cynthia, Ge Jin, Patidar Kavish R, Rubin Jessica, Sharma Arjun, Lai Jennifer C
Department of Medicine, University of California-San Francisco, San Francisco, California, USA.
Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Hepatology. 2025 Jan 1;81(1):126-135. doi: 10.1097/HEP.0000000000000858. Epub 2024 Mar 27.
This study informs how mean arterial pressure (MAP) impacts acute kidney injury (AKI) recovery among all patients hospitalized with cirrhosis, regardless of etiology.
We identified incident AKI episodes among subjects in our cohort of patients with decompensated cirrhosis. AKI was defined as a ≥50% increase in creatinine from an outpatient baseline (≥7 days prior) that required hospitalization. Linear mixed effects models were completed to determine the impact between AKI recovery, MAP, and time. To determine the impact of MAP on AKI reversal, we completed time-dependent Cox regression models with time beginning at the time of peak creatinine and ending at death, discharge, or AKI reversal, among those hospitalized with AKI and those with persistent AKI (≥48 h) We identified 702 hospitalized patients with cirrhosis with AKI. We found those with AKI reversal had, on average, higher MAP (2.1 mm Hg, p <0.05) and a greater increase in MAP over time (0.1 mm Hg per hour, p <0.001). Among all 702 hospitalized patients with AKI and adjusted for confounders, each 5 mm Hg increase in MAP was associated with 1.07× the hazard of AKI reversal ( p <0.01). Similarly, among those with persistent AKI after adjusting for confounders, each 5 mm Hg increase in MAP was associated with a 1.19× greater likelihood of AKI reversal ( p <0.001).
Our data demonstrate that MAP significantly increases the likelihood of AKI recovery regardless of severity or injury or AKI phenotype. We believe these data highlight the importance of MAP as a clinical tool to promote kidney function recovery among patients with cirrhosis hospitalized with AKI.
本研究旨在揭示平均动脉压(MAP)如何影响所有因肝硬化住院患者的急性肾损伤(AKI)恢复情况,无论其病因如何。
我们在失代偿期肝硬化患者队列中识别出急性肾损伤事件。AKI定义为肌酐水平较门诊基线(≥7天前)升高≥50%且需要住院治疗。采用线性混合效应模型来确定AKI恢复、MAP和时间之间的影响。为了确定MAP对AKI逆转的影响,我们对肌酐峰值时开始、死亡、出院或AKI逆转时结束的时间进行了时间依赖性Cox回归模型分析,分析对象为因AKI住院和持续性AKI(≥48小时)的患者。我们识别出702例因肝硬化住院且发生AKI的患者。我们发现,AKI逆转的患者平均MAP较高(高2.1 mmHg,p<0.05),且MAP随时间的升高幅度更大(每小时升高0.1 mmHg,p<0.001)。在所有702例因AKI住院的患者中,校正混杂因素后,MAP每升高5 mmHg与AKI逆转风险增加1.07倍相关(p<0.01)。同样,在校正混杂因素后的持续性AKI患者中,MAP每升高5 mmHg与AKI逆转可能性增加1.19倍相关(p<0.001)。
我们的数据表明,无论AKI的严重程度、损伤类型或表型如何,MAP均显著增加AKI恢复的可能性。我们认为这些数据凸显了MAP作为促进因AKI住院的肝硬化患者肾功能恢复的临床工具的重要性。